BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1551 – 1560 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Risk of male breast cancer in users of testosterone 5a reductase inhibitors
2016) 2016 Annual Meeting of the American Society of Clinical Oncology In Journal of Clinical Oncology 34(Suppl 15).(
- Contribution to journal › Published meeting abstract
-
Mark
Effects of high photon fluence rate from therapeutic radionuclides on preclinical and clinical PET systems
2016) IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014 In 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
(
- Contribution to journal › Scientific review
-
Mark
Socioeconomic inequalities in breast cancer incidence and mortality in Europe - A systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
The genomic landscape of core-binding factor acute myeloid leukemias
(
- Contribution to journal › Letter
-
Mark
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
(
- Contribution to journal › Article
-
Mark
Family History and Probability of Prostate Cancer, Differentiated by Risk Category : A Nationwide Population-Based Study
(
- Contribution to journal › Article
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
(
- Contribution to journal › Article